Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

US Patent 9808522 · Granted Nov 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing workpiece parts from a plate-shaped workpiece, data process2025
Method and device for removing a workpiece part from the remainder of the workpi2025
Atherosclerotic plaque detection2025
Valve with frangible fitting2024
Registration of white toner in an electrophotographic printer2023
Pushing out a plate-shaped workpiece part that has been cut free2023
Cutting a workpiece2022
Machines for the separative machining of plate-shaped workpieces2022
Method of treating atherosclerosis2021
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors a2021
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors a2021
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors a2021